montelukast

cysteinyl leukotriene receptor 1 ; Rattus norvegicus







22 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35013876 Montelukast suppresses the development of irritable bowel syndrome phenotype possibly through modulating NF-κB signaling in an experimental model. 2022 Feb 1
2 31309487 Cysteinyl leukotriene receptor antagonism: a promising pharmacological strategy for lowering the severity of arthritis. 2019 Oct 2
3 30222980 Montelukast attenuates rotenone-induced microglial activation/p38 MAPK expression in rats: Possible role of its antioxidant, anti-inflammatory and antiapoptotic effects. 2018 Nov 1 2
4 27909742 The anti-inflammatory effect of montelukast, a cysteinyl leukotriene receptor-1 antagonist, against estradiol-induced nonbacterial inflammation in the rat prostate. 2017 Feb 2
5 27881050 Pharmaceutical Rejuvenation of Age-Associated Decline in Spatial Memory. 2016 Dec 1
6 25403620 Montelukast, a cysteinyl leukotriene receptor-1 antagonist protects against hippocampal injury induced by transient global cerebral ischemia and reperfusion in rats. 2015 Jan 2
7 26442542 Effect of Montelukast on Spinal Cord Ischemia- Reperfusion Injury. 2015 1
8 26497763 The protective role of montelukast against intestinal ischemia-reperfusion injury in rats. 2015 Oct 26 1
9 26989383 The Effect of Montelukast on Liver Damage in an Experimental Obstructive Jaundice Model. 2015 Apr 2
10 24494466 Protective effect of montelukast, a cysteinyl leukotriene receptor-1 antagonist, against intestinal ischemia-reperfusion injury in the rat. 2013 Nov-Dec 1
11 22449377 Montelukast abrogates rhabdomyolysis-induced acute renal failure via rectifying detrimental changes in antioxidant profile and systemic cytokines and apoptotic factors production. 2012 May 15 3
12 22723160 [Effect of montelukast on morphological changes in neurons after ischemic injury]. 2012 May 1
13 19515388 Protective potential of montelukast against hepatic ischemia/reperfusion injury in rats. 2010 Mar 2
14 20467345 Montelukast, a selective cysteinyl leukotriene receptor 1 antagonist, reduces cerulein-induced pancreatic injury in rats. 2010 Oct 1
15 21105577 Involvement of cysteinyl leukotriene receptors in angiogenesis in rat thoracic aortic rings. 2010 Oct 1
16 19589545 Montelukast protects axial pattern rat skin flaps against ischemia/reperfusion injury. 2009 Dec 3
17 24692820 The effects of montelukast on random pattern skin flap survival: An experimental study in rats. 2008 Oct 1
18 17173892 Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist. 2007 Feb 14 4
19 17499745 Chronic renal failure-induced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast. 2007 Jun 2
20 16584888 Montelukast protects against renal ischemia/reperfusion injury in rats. 2006 Jul 3
21 12227087 [Potential gastroprotective effect of a CysLT1 receptor blocker sodium montelukast in aspirin-induced lesions of the rat stomach mucosa]. 2002 May-Jun 1
22 12418588 Leukotriene antagonism reduces the generation of endothelin-1 and interferon-gamma and inhibits eosinophilic airway inflammation. 2002 Nov 1